Given investment horizon of 30 days, China Sky One Medical Inc. is expected to under-perform the Integrated. But the stock apears to be less risky and, when comparing its historical volatility, China Sky One Medical Inc. is 33.88 times less risky than Integrated. The stock trades about -0.14 of its potential returns per unit of risk. The Integrated Biopharma Inc. is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 3.00 in Integrated Biopharma Inc. on April 25, 2012 and sell it today you would earn a total of 5.00 from holding Integrated Biopharma Inc. or generate 166.67% return on investment over 30 days.
Diversification
Significant diversification
Overlapping area represents amount of risk that can be diversified away by holding China Sky One Medical Inc. and Integrated Biopharma Inc. in the same portfolio (assuming nothing else is changed)
92% of all equities and portfolios perform better than Integrated Biopharma Inc.. Compared with the overall equity markets, risk-adjusted returns on investments in Integrated Biopharma Inc. are ranked lower than 8 (%) of all global equities and portfolios over the last 30 days.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
